Nakshatra Pharmaceuticals Private Limited
Pharmaceutical company that manufactures, imports, exports, and distributes various medical products.
1994 | Mumbai-400059, Maharashtra (India) | Active
Nakshatra Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Company Age 30 Year, 2 Months
- Open Charges ₹ 1.51 Cr
About Nakshatra Pharmaceuticals
Nakshatra Pharmaceuticals Private Limited (NPPL) is a Private Limited Indian Non-Government Company incorporated in India on 13 December 1994 and has a history of 30 years and two months. Its registered office is in Mumbai-400059, Maharashtra.
The Company is engaged in the Pharma Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.00.
The company currently has active open charges totaling ₹1.51 Cr.
Company Details
- Location Mumbai-400059, Maharashtra
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24239MH1994PTC083704
- Company No.
083704
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Dec 1994
- Date of AGM
-
- Date of Balance Sheet
-
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Pharma
Who are the key members and board of directors at Nakshatra Pharmaceuticals?
Board Members
No Directors or KMP associated with company. Upon reviewing the records, we can confirm that there are no Directors or Key Management Personnel (KMP) associated with this company at present.
Financial Performance of Nakshatra Pharmaceuticals.
Enhance accessibility to Nakshatra Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Nakshatra Pharmaceuticals?
Unlock access to Nakshatra Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
Open Charges
₹15.12 M
Satisfied Charges
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 1.20 Cr
- Oman International Bank Of India : 0.30 Cr
- Andhra Bank : 0.01 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 12 Apr 1998 | Oman International Bank Of India | ₹3.00 M | Open |
| 02 Sep 1997 | Andhra Bank | ₹0.13 M | Open |
| 04 Dec 1990 | State Bank Of India | ₹0.49 M | Open |
| 09 Jan 1987 | State Bank Of India | ₹1.15 Cr | Open |
How Many Employees Work at Nakshatra Pharmaceuticals?
Unlock and access historical data on people associated with Nakshatra Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nakshatra Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nakshatra Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.